EnBio is an indigenous Irish technology company founded in 2006, that develops specialised coatings used for medical implants in orthopaedic surgery such as knees, hips and spinal procedures.

EnBio has developed a novel, low temperature and low cost processing technology for the application of materials onto metal surfaces such as titanium, CoCr, NiTi, and stainless steel.  The focus of this patent pending technology know as CoBlast has been on treatments for hard tissue implants.  EnBio is working to exploit this technology with its OsteoZip surface for enhancing cell adhesion onto orthopaedic and dental devices.  A second application area involves the incorporation of drugs into the CoBlast deposited bioceramic coatings.  The recently-launched OsteoZap is an infection preventing surface for any implants.

The flexibility of the CoBlast process offers enormous potential.  It can be used to deposit novel functionalities to the surface of any metallic implant.  Compared with conventional processing technologies, no high energy plasma sources, vacuum systems or chemical solution containment are required.  EnBio believes that this capability will lead to the development of new ideas and product concepts not heretofore considered.  EnBio offers a fully integrated single supplier solution for end-user surface modification requirements.  This includes support and consultancy to tailor the CoBlast process to meet end-user surface requirements, as well as the supply of equipment and media.

"EnBio is very excited about its partnership with REMEDI and the potential of this relationship to significantly enhance the novelty of the medical implant surface technologies which EnBio can offer its customers amd the potential benefits that will eventually be experienced by patients."

John O' Donoghue, EnBio's founder and CTO

More information from www.enbiomaterials.com